Cognitive control and the dopamine D 2-like receptor: A dimensional understanding of addiction

Depression and Anxiety

Volumn 29, Issue 4, 2012, Pages 295-306

  Groman, Stephanie M ^a   Jentsch, J David ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

addiction; cognitive control; D 2 receptor; dopamine; impulsivity; mental disorders

Indexed keywords

DOPAMINE; DOPAMINE 2 RECEPTOR;

ADDICTION; COGNITION; CONFERENCE PAPER; EXECUTIVE FUNCTION; HUMAN; IMPULSIVENESS; PHENOTYPE; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; TREATMENT RESPONSE;

BEHAVIOR, ADDICTIVE; BIOLOGICAL MARKERS; DOPAMINE; HUMANS; IMPULSIVE BEHAVIOR; INHIBITION (PSYCHOLOGY); MENTAL DISORDERS; RECEPTORS, DOPAMINE D2;

EID: 84856686314     PISSN: 10914269     EISSN: 15206394     Source Type: Journal    
DOI: 10.1002/da.20897     Document Type: Conference Paper

References (211)

1. Volkow ND, Wang GJ, Fowler JS, Telang F,. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos Trans R Soc Lond B Biol Sci 2008; 363: 3191-3200.
2. Garcia FD, Thibaut F,. Sexual addictions. Am J Drug Alcohol Abuse 2010; 36: 254-260.
3. Jentsch JD, Taylor JR,. Impulsivity resulting from frontostriatal dysfunction in drug abuse: implications for the control of behavior by reward-related stimuli. Psychopharmacology (Berl) 1999; 146: 373-390. (Pubitemid 29513278)
4. Dawe S, Loxton NJ,. The role of impulsivity in the development of substance use and eating disorders. Neurosci Biobehav Rev 2004; 28: 343-351. (Pubitemid 38844381)
5. Winstanley CA, Eagle DM, Robbins TW,. Behavioral models of impulsivity in relation to ADHD: translation between clinical and preclinical studies. Clin Psychol Rev 2006; 26: 379-395.
6. Monterosso JR, Ainslie G, Xu J, Cordova X, Domier CP, London ED,. Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task. Hum Brain Mapp 2007; 28: 383-393. (Pubitemid 46717363)
7. Coffey SF, Gudleski GD, Saladin ME, Brady KT,. Impulsivity and rapid discounting of delayed hypothetical rewards in cocaine-dependent individuals. Exp Clin Psychopharmacol 2003; 11: 18-25. (Pubitemid 36237339)
8. Bickel WK, Odum AL, Madden GJ,. Impulsivity and cigarette smoking: delay discounting in current, never, and ex-smokers. Psychopharmacology (Berl) 1999; 146: 447-454. (Pubitemid 29513285)
9. Weller RE, Cook 3rd EW, Avsar KB, Cox JE,. Obese women show greater delay discounting than healthy-weight women. Appetite 2008; 51: 563-569.
10. Alessi SM, Petry NM,. Pathological gambling severity is associated with impulsivity in a delay discounting procedure. Behav Processes 2003; 64: 345-354. (Pubitemid 37324378)
11. Beck A, Schlagenhauf F, Wustenberg T, et al. Ventral striatal activation during reward anticipation correlates with impulsivity in alcoholics. Biol Psychiatry 2009; 66: 734-742.
12. Lee B, London ED, Poldrack RA, et al. Striatal dopamine d2/d3 receptor availability is reduced in methamphetamine dependence and is linked to impulsivity. J Neurosci 2009; 29: 14734-14740.
13. Mitchell SH,. Measures of impulsivity in cigarette smokers and non-smokers. Psychopharmacology (Berl) 1999; 146: 455-464. (Pubitemid 29513286)
14. Madden GJ, Petry NM, Badger GJ, Bickel WK,. Impulsive and self-control choices in opioid-dependent patients and non-drug-using control participants: drug and monetary rewards. Exp Clin Psychopharmacol 1997; 5: 256-262. (Pubitemid 27346450)
15. Fuentes D, Tavares H, Artes R, Gorenstein C,. Self-reported and neuropsychological measures of impulsivity in pathological gambling. J Int Neuropsychol Soc 2006; 12: 907-912. (Pubitemid 46415896)
16. Nasser JA, Gluck ME, Geliebter A,. Impulsivity and test meal intake in obese binge eating women. Appetite 2004; 43: 303-307. (Pubitemid 39440997)
17. Roesch MR, Takahashi Y, Gugsa N, Bissonette GB, Schoenbaum G,. Previous cocaine exposure makes rats hypersensitive to both delay and reward magnitude. J Neurosci 2007; 27: 245-250. (Pubitemid 46089978)
18. Richards JB, Zhang L, Mitchell SH, de Wit H,. Delay or probability discounting in a model of impulsive behavior: effect of alcohol. J Exp Anal Behav 1999; 71: 121-143.
19. Dallery J, Locey ML,. Effects of acute and chronic nicotine on impulsive choice in rats. Behav Pharmacol 2005; 16: 15-23. (Pubitemid 40354362)
20. Ersche KD, Turton AJ, Pradhan S, Bullmore ET, Robbins TW,. Drug addiction endophenotypes: impulsive versus sensation-seeking personality traits. Biol Psychiatry 2010; 68: 770-773.
21. Verdejo-Garcia A, Lawrence AJ, Clark L,. Impulsivity as a vulnerability marker for substance-use disorders: review of findings from high-risk research, problem gamblers and genetic association studies. Neurosci Biobehav Rev 2008; 32: 777-810.
22. Esposito-Smythers C, Spirito A, Rizzo C, McGeary JE, Knopik VS,. Associations of the DRD2 TaqIA polymorphism with impulsivity and substance use: preliminary results from a clinical sample of adolescents. Pharmacol Biochem Behav 2009; 93: 306-312.
23. Perry JL, Larson EB, German JP, Madden GJ, Carroll ME,. Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats. Psychopharmacology (Berl) 2005; 178: 193-201. (Pubitemid 40379214)
24. Perry JL, Nelson SE, Carroll ME,. Impulsive choice as a predictor of acquisition of IV cocaine self-administration and reinstatement of cocaine-seeking behavior in male and female rats. Exp Clin Psychopharmacol 2008; 16: 165-177. (Pubitemid 351680709)
25. Dalley JW, Fryer TD, Brichard L, et al. Nucleus accumbens D2/3 receptors predict trait impulsivity and cocaine reinforcement. Science 2007; 315: 1267-1270. (Pubitemid 46364262)
26. Anker JJ, Perry JL, Gliddon LA, Carroll ME,. Impulsivity predicts the escalation of cocaine self-administration in rats. Pharmacol Biochem Behav 2009; 93: 343-348.
27. Belin D, Mar AC, Dalley JW, Robbins TW, Everitt BJ,. High impulsivity predicts the switch to compulsive cocaine-taking. Science 2008; 320: 1352-1355. (Pubitemid 351929473)
28. Miller EK, Cohen JD,. An integrative theory of prefrontal cortex function. Annu Rev Neurosci 2001; 24: 167-202. (Pubitemid 32695227)
29. Fillmore MT, Rush CR,. Polydrug abusers display impaired discrimination-reversal learning in a model of behavioural control. J Psychopharmacol 2006; 20: 24-32.
30. Ersche KD, Roiser JP, Robbins TW, Sahakian BJ,. Chronic cocaine but not chronic amphetamine use is associated with perseverative responding in humans. Psychopharmacology (Berl) 2008; 197: 421-431.
31. Kubler A, Murphy K, Garavan H,. Cocaine dependence and attention switching within and between verbal and visuospatial working memory. Eur J Neurosci 2005; 21: 1984-1992. (Pubitemid 40685876)
32. Kalechstein AD, De La Garza 2nd R, Newton TF,. Modafinil administration improves working memory in methamphetamine-dependent individuals who demonstrate baseline impairment. Am J Addict 2010; 19: 340-344.
33. Indlekofer F, Piechatzek M, Daamen M, et al. Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol. J Psychopharmacol 2009; 23: 495-509.
34. James AS, Groman SM, Seu E, Jorgensen M, Fairbanks LA, Jentsch JD,. Dimensions of impulsivity are associated with poor spatial working memory performance in monkeys. J Neurosci 2007; 27: 14358-14364.
35. Groman SM, James AS, Fairbanks LA, Seu E, Jentsch JD,. Behavioral impulsivity is predictive of the reversal, but not acquisition or retention, of a visual discrimination in juvenile vervet monkeys. Paper presented at the Society for Neuroscience, Washington, DC; 2007.
36. Romer D, Betancourt L, Giannetta JM, Brodsky NL, Farah M, Hurt H,. Executive cognitive functions and impulsivity as correlates of risk taking and problem behavior in preadolescents. Neuropsychologia 2009; 47: 2916-2926.
37. Jentsch JD, Olausson P, De La Garza R, Taylor 2nd JR,. Impairments of reversal learning and response perseveration after repeated, intermittent cocaine administrations to monkeys. Neuropsychopharmacology 2002; 26: 183-190. (Pubitemid 34093081)
38. Crean RD, Vandewater SA, Katner SN, Huitron-Resendiz S, Taffe MA,. Chronic alcohol consumption impairs visuo-spatial associative memory in periadolescent rhesus monkeys. Drug Alcohol Depend 2011; 114: 31-40.
39. Porter JN, Olsen AS, Gurnsey K, Dugan BP, Jedema HP, Bradberry CW,. Chronic cocaine self-administration in rhesus monkeys: impact on associative learning, cognitive control, and working memory. J Neurosci 2011; 31: 4926-4934.
40. Deckel AW, Hesselbrock V,. Behavioral and cognitive measurements predict scores on the MAST: a 3-year prospective study. Alcohol Clin Exp Res 1996; 20: 1173-1178. (Pubitemid 26357016)
41. Giancola PR, Moss HB, Martin CS, Kirisci L, Tarter RE,. Executive cognitive functioning predicts reactive aggression in boys at high risk for substance abuse: a prospective study. Alcohol Clin Exp Res 1996; 20: 740-744. (Pubitemid 26186943)
42. Aytaclar S, Tarter RE, Kirisci L, Lu S,. Association between hyperactivity and executive cognitive functioning in childhood and substance use in early adolescence. J Am Acad Child Adolesc Psychiatry 1999; 38: 172-178. (Pubitemid 29061933)
43. Dellu-Hagedorn F,. Spontaneous individual differences in cognitive performances of young adult rats predict locomotor response to amphetamine. Neurobiol Learn Mem 2005; 83: 43-47. (Pubitemid 40018025)
44. Klingberg T, Forssberg H, Westerberg H,. Training of working memory in children with ADHD. J Clin Exp Neuropsychol 2002; 24: 781-791. (Pubitemid 36042856)
45. Groman SM, James AS, Jentsch JD,. Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder. Neurosci Biobehav Rev 2009; 33: 690-698.
46. Anderson AL, Reid MS, Li SH, et al. Modafinil for the treatment of cocaine dependence. Drug Alcohol Depend 2009; 104: 133-139.
47. Dackis CA, Kampman KM, Lynch KG, Pettinati HM, O'Brien CP,. A double-blind, placebo-controlled trial of modafinil for cocaine dependence. Neuropsychopharmacology 2005; 30: 205-211. (Pubitemid 40024415)
48. Shearer J, Darke S, Rodgers C, et al. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence. Addiction 2009; 104: 224-233.
49. Aharonovich E, Hasin DS, Brooks AC, Liu X, Bisaga A, Nunes EV,. Cognitive deficits predict low treatment retention in cocaine dependent patients. Drug Alcohol Depend 2006; 81: 313-322. (Pubitemid 43152458)
50. Moeller FG, Dougherty DM, Barratt ES, Schmitz JM, Swann AC, Grabowski J,. The impact of impulsivity on cocaine use and retention in treatment. J Subst Abuse Treat 2001; 21: 193-198. (Pubitemid 34037109)
51. Bowden-Jones H, McPhillips M, Rogers R, Hutton S, Joyce E,. Risk-taking on tests sensitive to ventromedial prefrontal cortex dysfunction predicts early relapse in alcohol dependency: a pilot study. J Neuropsychiatry Clin Neurosci 2005; 17: 417-420. (Pubitemid 46179307)
52. Haber SN,. The primate basal ganglia: parallel and integrative networks. J Chem Neuroanat 2003; 26: 317-330. (Pubitemid 38077155)
53. Redgrave P, Rodriguez M, Smith Y, et al. Goal-directed and habitual control in the basal ganglia: implications for Parkinson's disease. Nat Rev Neurosci 2010; 11: 760-772.
54. Tanabe J, Tregellas JR, Dalwani M, et al. Medial orbitofrontal cortex gray matter is reduced in abstinent substance-dependent individuals. Biol Psychiatry 2009; 65: 160-164.
55. Franklin TR, Acton PD, Maldjian JA, et al. Decreased gray matter concentration in the insular, orbitofrontal, cingulate, and temporal cortices of cocaine patients. Biol Psychiatry 2002; 51: 134-142. (Pubitemid 34127903)
56. Schwartz DL, Mitchell AD, Lahna DL, et al. Global and local morphometric differences in recently abstinent methamphetamine-dependent individuals. Neuroimage 2010; 50: 1392-1401.
57. Thompson PM, Hayashi KM, Simon SL, et al. Structural abnormalities in the brains of human subjects who use methamphetamine. J Neurosci 2004; 24: 6028-6036. (Pubitemid 38859399)
58. Liu H, Hao Y, Kaneko Y, et al. Frontal and cingulate gray matter volume reduction in heroin dependence: optimized voxel-based morphometry. Psychiatry Clin Neurosci 2009; 63: 563-568.
59. Yuan K, Qin W, Dong M, et al. Gray matter deficits and resting-state abnormalities in abstinent heroin-dependent individuals. Neurosci Lett 2010; 482: 101-105.
60. Jang DP, Namkoong K, Kim JJ, et al. The relationship between brain morphometry and neuropsychological performance in alcohol dependence. Neurosci Lett 2007; 428: 21-26. (Pubitemid 47633807)
61. Fein G, Di Sclafani V, Cardenas VA, Goldmann H, Tolou-Shams M, Meyerhoff DJ,. Cortical gray matter loss in treatment-naive alcohol dependent individuals. Alcohol Clin Exp Res 2002; 26: 558-564. (Pubitemid 34408722)
62. Liu X, Matochik JA, Cadet JL, London ED,. Smaller volume of prefrontal lobe in polysubstance abusers: a magnetic resonance imaging study. Neuropsychopharmacology 1998; 18: 243-252. (Pubitemid 28085523)
63. Maayan L, Hoogendoorn C, Sweat V, Convit A,. Disinhibited eating in obese adolescents is associated with orbitofrontal volume reductions and executive dysfunction. Obesity (Silver Spring) 2011; 7: 1382-1387.
64. Raji CA, Ho AJ, Parikshak NN, et al. Brain structure and obesity. Hum Brain Mapp 2010; 31: 353-364.
65. Lim KO, Choi SJ, Pomara N, Wolkin A, Rotrosen JP,. Reduced frontal white matter integrity in cocaine dependence: a controlled diffusion tensor imaging study. Biol Psychiatry 2002; 51: 890-895. (Pubitemid 34521937)
66. Chung A, Lyoo IK, Kim SJ, et al. Decreased frontal white-matter integrity in abstinent methamphetamine abusers. Int J Neuropsychopharmacol 2007; 10: 765-775. (Pubitemid 350035821)
67. Volkow ND, Fowler JS, Wang GJ, et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993; 14: 169-177. (Pubitemid 23157765)
68. Kim YT, Lee SW, Kwon DH, Seo JH, Ahn BC, Lee J,. Dose-dependent frontal hypometabolism on FDG-PET in methamphetamine abusers. J Psychiatr Res 2009; 43: 1166-1170.
69. Kim SJ, Lyoo IK, Hwang J, et al. Frontal glucose hypometabolism in abstinent methamphetamine users. Neuropsychopharmacology 2005; 30: 1383-1391. (Pubitemid 40848092)
70. London ED, Simon SL, Berman SM, et al. Mood disturbances and regional cerebral metabolic abnormalities in recently abstinent methamphetamine abusers. Arch Gen Psychiatry 2004; 61: 73-84. (Pubitemid 38044643)
71. Sevy S, Smith GS, Ma Y, et al. Cerebral glucose metabolism and D2/D3 receptor availability in young adults with cannabis dependence measured with positron emission tomography. Psychopharmacology (Berl) 2008; 197: 549-556.
72. Crombag HS, Gorny G, Li Y, Kolb B, Robinson TE,. Opposite effects of amphetamine self-administration experience on dendritic spines in the medial and orbital prefrontal cortex. Cereb Cortex 2005; 15: 341-348. (Pubitemid 40270203)
73. Robinson TE, Gorny G, Mitton E, Kolb B,. Cocaine self-administration alters the morphology of dendrites and dendritic spines in the nucleus accumbens and neocortex. Synapse 2001; 39: 257-266. (Pubitemid 32099681)
74. Robinson TE, Kolb B,. Persistent structural modifications in nucleus accumbens and prefrontal cortex neurons produced by previous experience with amphetamine. J Neurosci 1997; 17: 8491-8497. (Pubitemid 27461070)
75. Hammer Jr RP, Pires WS, Markou A, Koob GF,. Withdrawal following cocaine self-administration decreases regional cerebral metabolic rate in critical brain reward regions. Synapse 1993; 14: 73-80. (Pubitemid 23138180)
76. Porrino LJ, Lyons D, Smith HR, Daunais JB, Nader MA,. Cocaine self-administration produces a progressive involvement of limbic, association, and sensorimotor striatal domains. J Neurosci 2004; 24: 3554-3562. (Pubitemid 38481112)
77. Benegal V, Antony G, Venkatasubramanian G, Jayakumar PN,. Gray matter volume abnormalities and externalizing symptoms in subjects at high risk for alcohol dependence. Addict Biol 2007; 12: 122-132. (Pubitemid 46405996)
78. Weissenborn R, Robbins TW, Everitt BJ,. Effects of medial prefrontal or anterior cingulate cortex lesions on responding for cocaine under fixed-ratio and second-order schedules of reinforcement in rats. Psychopharmacology (Berl) 1997; 134: 242-257. (Pubitemid 27520978)
79. Bechara A, Tranel D, Damasio H,. Characterization of the decision-making deficit of patients with ventromedial prefrontal cortex lesions. Brain 2000; 123: 2189-2202.
80. Berlin HA, Rolls ET, Kischka U,. Impulsivity, time perception, emotion and reinforcement sensitivity in patients with orbitofrontal cortex lesions. Brain 2004; 127: 1108-1126. (Pubitemid 38623046)
81. Chudasama Y, Baunez C, Robbins TW,. Functional disconnection of the medial prefrontal cortex and subthalamic nucleus in attentional performance: evidence for corticosubthalamic interaction. J Neurosci 2003; 23: 5477-5485. (Pubitemid 36807822)
82. Rogers RD, Baunez C, Everitt BJ, Robbins TW,. Lesions of the medial and lateral striatum in the rat produce differential deficits in attentional performance. Behav Neurosci 2001; 115: 799-811. (Pubitemid 32738326)
83. Cardinal RN, Pennicott DR, Sugathapala CL, Robbins TW, Everitt BJ,. Impulsive choice induced in rats by lesions of the nucleus accumbens core. Science 2001; 292: 2499-2501. (Pubitemid 32601663)
84. Matsuo K, Nicoletti M, Nemoto K, et al. A voxel-based morphometry study of frontal gray matter correlates of impulsivity. Hum Brain Mapp 2009; 30: 1188-1195.
85. Carmona S, Proal E, Hoekzema EA, et al. Ventro-striatal reductions underpin symptoms of hyperactivity and impulsivity in attention-deficit/ hyperactivity disorder. Biol Psychiatry 2009; 66: 972-977.
86. Bjork JM, Momenan R, Hommer DW,. Delay discounting correlates with proportional lateral frontal cortex volumes. Biol Psychiatry 2009; 65: 710-713.
87. Aron AR, Fletcher PC, Bullmore ET, Sahakian BJ, Robbins TW,. Stop-signal inhibition disrupted by damage to right inferior frontal gyrus in humans. Nat Neurosci 2003; 6: 115-116. (Pubitemid 36182778)
88. Szatkowska I, Szymanska O, Bojarski P, Grabowska A,. Cognitive inhibition in patients with medial orbitofrontal damage. Exp Brain Res 2007; 181: 109-115. (Pubitemid 47029996)
89. Swick D, Ashley V, Turken AU,. Left inferior frontal gyrus is critical for response inhibition. BMC Neurosci 2008; 9: 102.
90. Iversen SD Mishkin M,. Perseverative interference in monkeys following selective lesions of the inferior prefrontal convexity. Exp Brain Res 1970; 11: 376-386.
91. Funahashi S, Bruce CJ, Goldman-Rakic PS,. Dorsolateral prefrontal lesions and oculomotor delayed-response performance: evidence for mnemonic "scotomas." J Neurosci 1993; 13: 1479-1497. (Pubitemid 23095392)
92. du Boisgueheneuc F, Levy R, Volle E, et al. Functions of the left superior frontal gyrus in humans: a lesion study. Brain 2006; 129: 3315-3328. (Pubitemid 44871445)
93. Manes F, Sahakian B, Clark L, et al. Decision-making processes following damage to the prefrontal cortex. Brain 2002; 125: 624-639. (Pubitemid 34194416)
94. Godefroy O, Rousseaux M,. Divided and focused attention in patients with lesion of the prefrontal cortex. Brain Cogn 1996; 30: 155-174. (Pubitemid 26369249)
95. Dias R, Robbins TW, Roberts AC,. Primate analogue of the Wisconsin Card Sorting Test: effects of excitotoxic lesions of the prefrontal cortex in the marmoset. Behav Neurosci 1996; 110: 872-886. (Pubitemid 26365787)
96. Dias R, Aggleton JP,. Effects of selective excitotoxic prefrontal lesions on acquisition of nonmatching- and matching-to-place in the T-maze in the rat: differential involvement of the prelimbic-infralimbic and anterior cingulate cortices in providing behavioural flexibility. Eur J Neurosci 2000; 12: 4457-4466. (Pubitemid 32037854)
97. Hornak J, O'Doherty J, Bramham J, et al. Reward-related reversal learning after surgical excisions in orbito-frontal or dorsolateral prefrontal cortex in humans. J Cogn Neurosci 2004; 16: 463-478. (Pubitemid 38392404)
98. Rygula R, Walker SC, Clarke HF, Robbins TW, Roberts AC,. Differential contributions of the primate ventrolateral prefrontal and orbitofrontal cortex to serial reversal learning. J Neurosci 2010; 30: 14552-14559.
99. Castane A, Theobald DE, Robbins TW,. Selective lesions of the dorsomedial striatum impair serial spatial reversal learning in rats. Behav Brain Res 2010; 210: 74-83.
100. Clarke HF, Robbins TW, Roberts AC,. Lesions of the medial striatum in monkeys produce perseverative impairments during reversal learning similar to those produced by lesions of the orbitofrontal cortex. J Neurosci 2008; 28: 10972-10982.
101. Floresco SB, Seamans JK, Phillips AG,. Selective roles for hippocampal, prefrontal cortical, and ventral striatal circuits in radial-arm maze tasks with or without a delay. J Neurosci 1997; 17: 1880-1890. (Pubitemid 27089832)
102. Levy R, Friedman HR, Davachi L, Goldman-Rakic PS,. Differential activation of the caudate nucleus in primates performing spatial and nonspatial working memory tasks. J Neurosci 1997; 17: 3870-3882. (Pubitemid 27200609)
103. Ghahremani DG, Monterosso J, Jentsch JD, Bilder RM, Poldrack RA,. Neural components underlying behavioral flexibility in human reversal learning. Cereb Cortex 2010; 20: 1843-1852.
104. Xue G, Ghahremani DG, Poldrack RA,. Neural substrates for reversing stimulus-outcome and stimulus-response associations. J Neurosci 2008; 28: 11196-11204.
105. Dickstein DP, Finger EC, Brotman MA, et al. Impaired probabilistic reversal learning in youths with mood and anxiety disorders. Psychol Med 2010; 40: 1089-1100.
106. Taylor Tavares JV, Clark L, Furey ML, Williams GB, Sahakian BJ, Drevets WC,. Neural basis of abnormal response to negative feedback in unmedicated mood disorders. Neuroimage 2008; 42: 1118-1126.
107. McKirdy J, Sussmann JE, Hall J, Lawrie SM, Johnstone EC, McIntosh AM,. Set shifting and reversal learning in patients with bipolar disorder or schizophrenia. Psychol Med 2009; 39: 1289-1293.
108. Maalouf FT, Klein C, Clark L, et al. Impaired sustained attention and executive dysfunction: bipolar disorder versus depression-specific markers of affective disorders. Neuropsychologia 2010; 48: 1862-1868.
109. Houenou J, Frommberger J, Carde S, et al. Neuroimaging-based markers of bipolar disorder: evidence from two meta-analyses. J Affect Disord 2011; 132: 344-355.
110. Foland-Ross LC, Thompson PM, Sugar CA, et al. Investigation of cortical thickness abnormalities in lithium-free adults with bipolar I disorder using cortical pattern matching. Am J Psychiatry 2011; 168: 530-539.
111. Chang CC, Yu SC, McQuoid DR, et al. Reduction of dorsolateral prefrontal cortex gray matter in late-life depression. Psychiatry Res 2011; 193: 1-6.
112. Ballmaier M, Toga AW, Blanton RE, et al. Anterior cingulate, gyrus rectus, and orbitofrontal abnormalities in elderly depressed patients: an MRI-based parcellation of the prefrontal cortex. Am J Psychiatry 2004; 161: 99-108. (Pubitemid 38419314)
113. van Tol MJ, van der Wee NJ, van den Heuvel OA, et al. Regional brain volume in depression and anxiety disorders. Arch Gen Psychiatry 2010; 67: 1002-1011.
114. Carr DB, Sesack SR,. Dopamine terminals synapse on callosal projection neurons in the rat prefrontal cortex. J Comp Neurol 2000; 425: 275-283. (Pubitemid 30660452)
115. Karreman M, Moghaddam B,. The prefrontal cortex regulates the basal release of dopamine in the limbic striatum: an effect mediated by ventral tegmental area. J Neurochem 1996; 66: 589-598. (Pubitemid 26036693)
116. Pycock CJ, Kerwin RW, Carter CJ,. Effect of lesion of cortical dopamine terminals on subcortical dopamine receptors in rats. Nature 1980; 286: 74-76.
117. Carlson JN, Visker KE, Keller Jr RW, Glick SD,. Left and right 6-hydroxydopamine lesions of the medial prefrontal cortex differentially alter subcortical dopamine utilization and the behavioral response to stress. Brain Res 1996; 711: 1-9. (Pubitemid 26081839)
118. Martin-Iverson MT, Szostak C, Fibiger HC,. 6-Hydroxydopamine lesions of the medial prefrontal cortex fail to influence intravenous self-administration of cocaine. Psychopharmacology (Berl) 1986; 88: 310-314. (Pubitemid 16131115)
119. Deutch AY, Clark WA, Roth RH,. Prefrontal cortical dopamine depletion enhances the responsiveness of mesolimbic dopamine neurons to stress. Brain Res 1990; 521: 311-315. (Pubitemid 20208767)
120. Mitchell JB, Gratton A,. Partial dopamine depletion of the prefrontal cortex leads to enhanced mesolimbic dopamine release elicited by repeated exposure to naturally reinforcing stimuli. J Neurosci 1992; 12: 3609-3618.
121. Roberts AC, De Salvia MA, Wilkinson LS, et al. 6-Hydroxydopamine lesions of the prefrontal cortex in monkeys enhance performance on an analog of the Wisconsin Card Sort Test: possible interactions with subcortical dopamine. J Neurosci 1994; 14: 2531-2544. (Pubitemid 24140883)
122. Pontieri FE, Tanda G, Di Chiara G,. Intravenous cocaine, morphine, and amphetamine preferentially increase extracellular dopamine in the "shell" as compared with the "core" of the rat nucleus accumbens. Proc Natl Acad Sci USA 1995; 92: 12304-12308.
123. Di Chiara G, Imperato A,. Drugs abused by humans preferentially increase synaptic dopamine concentrations in the mesolimbic system of freely moving rats. Proc Natl Acad Sci USA 1988; 85: 5274-5278.
124. Pfaus JG, Damsma G, Wenkstern D, Fibiger HC,. Sexual activity increases dopamine transmission in the nucleus accumbens and striatum of female rats. Brain Res 1995; 693: 21-30.
125. Bassareo V, Di Chiara G,. Differential influence of associative and nonassociative learning mechanisms on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum. J Neurosci 1997; 17: 851-861. (Pubitemid 27024596)
126. Berridge KC, Robinson TE,. What is the role of dopamine in reward: hedonic impact, reward learning, or incentive salience? Brain Res Brain Res Rev 1998; 28: 309-369. (Pubitemid 29012677)
127. Wilson JM, Nobrega JN, Corrigall W, Shannak K, Deck JH, Kish SJ,. Influence of chronic cocaine on monoamine neurotransmitters in human brain and animal model: preliminary observations. Ann N Y Acad Sci 1992; 654: 461-463.
128. Little KY, Ramssen E, Welchko R, Volberg V, Roland CJ, Cassin B,. Decreased brain dopamine cell numbers in human cocaine users. Psychiatry Res 2009; 168: 173-180.
129. Kish SJ, Kalasinsky KS, Derkach P, et al. Striatal dopaminergic and serotonergic markers in human heroin users. Neuropsychopharmacology 2001; 24: 561-567. (Pubitemid 32244316)
130. Maisonneuve IM, Ho A, Kreek MJ,. Chronic administration of a cocaine "binge" alters basal extracellular levels in male rats: an in vivo microdialysis study. J Pharmacol Exp Ther 1995; 272: 652-657.
131. Henry PK, Howell LL,. Cocaine-induced reinstatement during limited and extended drug access conditions in rhesus monkeys. Psychopharmacology (Berl) 2009; 204: 523-529.
132. Sorg BA, Davidson DL, Kalivas PW, Prasad BM,. Repeated daily cocaine alters subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex. J Pharmacol Exp Ther 1997; 281: 54-61. (Pubitemid 27203051)
133. Segal DS, Kuczenski R,. In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment. Brain Res 1992; 571: 330-337.
134. Segal DS, Kuczenski R,. Repeated cocaine administration induces behavioral sensitization and corresponding decreased extracellular dopamine responses in caudate and accumbens. Brain Res 1992; 577: 351-355.
135. Lee J, Parish CL, Tomas D, Horne MK,. Chronic cocaine administration reduces striatal dopamine terminal density and striatal dopamine release which leads to drug-seeking behaviour. Neuroscience 2011; 174: 143-150.
136. Martinez D, Narendran R, Foltin RW, et al. Amphetamine-induced dopamine release: markedly blunted in cocaine dependence and predictive of the choice to self-administer cocaine. Am J Psychiatry 2007; 164: 622-629. (Pubitemid 46650194)
137. Martinez D, Greene K, Broft A, et al. Lower level of endogenous dopamine in patients with cocaine dependence: findings from PET imaging of D(2)/D(3) receptors following acute dopamine depletion. Am J Psychiatry 2009; 166: 1170-1177.
138. Volkow ND, Wang GJ, Fowler JS, et al. Decreased striatal dopaminergic responsiveness in detoxified cocaine-dependent subjects. Nature 1997; 386: 830-833. (Pubitemid 27181256)
139. Volkow ND, Wang GJ, Telang F, et al. Profound decreases in dopamine release in striatum in detoxified alcoholics: possible orbitofrontal involvement. J Neurosci 2007; 27: 12700-12706. (Pubitemid 350127825)
140. Heinz A, Siessmeier T, Wrase J, et al. Correlation of alcohol craving with striatal dopamine synthesis capacity and D2/3 receptor availability: a combined [18F]DOPA and [18F]DMFP PET study in detoxified alcoholic patients. Am J Psychiatry 2005; 162: 1515-1520. (Pubitemid 41105567)
141. Melega WP, Jorgensen MJ, Lacan G, et al. Long-term methamphetamine administration in the vervet monkey models aspects of a human exposure: brain neurotoxicity and behavioral profiles. Neuropsychopharmacology 2008; 33: 1441-1452. (Pubitemid 351521710)
142. Biederman J, Wilens T, Mick E, Milberger S, Spencer TJ, Faraone SV,. Psychoactive substance use disorders in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. Am J Psychiatry 1995; 152: 1652-1658.
143. Lee SS, Humphreys KL, Flory K, Liu R, Glass K,. Prospective association of childhood attention-deficit/hyperactivity disorder (ADHD) and substance use and abuse/dependence: a meta-analytic review. Clin Psychol Rev 2011; 31: 328-341.
144. Rosa-Neto P, Lou HC, Cumming P, et al. Methylphenidate-evoked changes in striatal dopamine correlate with inattention and impulsivity in adolescents with attention deficit hyperactivity disorder. Neuroimage 2005; 25: 868-876. (Pubitemid 40461725)
145. Volkow ND, Wang GJ, Newcorn J, et al. Depressed dopamine activity in caudate and preliminary evidence of limbic involvement in adults with attention-deficit/hyperactivity disorder. Arch Gen Psychiatry 2007; 64: 932-940. (Pubitemid 47230617)
146. George SR, Fan T, Ng GY, Jung SY, O'Dowd BF, Naranjo CA,. Low endogenous dopamine function in brain predisposes to high alcohol preference and consumption: reversal by increasing synaptic dopamine. J Pharmacol Exp Ther 1995; 273: 373-379.
147. Gongwer MA, Murphy JM, McBride WJ, Lumeng L, Li TK,. Regional brain contents of serotonin, dopamine and their metabolites in the selectively bred high- and low-alcohol drinking lines of rats. Alcohol 1989; 6: 317-320.
148. Quintanilla ME, Bustamante D, Tampier L, Israel Y, Herrera-Marschitz M,. Dopamine release in the nucleus accumbens (shell) of two lines of rats selectively bred to prefer or avoid ethanol. Eur J Pharmacol 2007; 573: 84-92. (Pubitemid 47464205)
149. Buckholtz JW, Treadway MT, Cowan RL, et al. Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Nat Neurosci 2010; 13: 419-421.
150. Pine A, Shiner T, Seymour B, Dolan RJ,. Dopamine, time, and impulsivity in humans. J Neurosci 2010; 30: 8888-8896.
151. Cools R, Barker RA, Sahakian BJ, Robbins TW,. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease. Neuropsychologia 2003; 41: 1431-1441. (Pubitemid 36808816)
152. Cole BJ, Robbins TW,. Effects of 6-hydroxydopamine lesions of the nucleus accumbens septi on performance of a 5-choice serial reaction time task in rats: implications for theories of selective attention and arousal. Behav Brain Res 1989; 33: 165-179. (Pubitemid 19141065)
153. Baunez C, Robbins TW,. Effects of dopamine depletion of the dorsal striatum and further interaction with subthalamic nucleus lesions in an attentional task in the rat. Neuroscience 1999; 92: 1343-1356. (Pubitemid 29292570)
154. Brozoski TJ, Brown RM, Rosvold HE, Goldman PS,. Cognitive deficit caused by regional depletion of dopamine in prefrontal cortex of rhesus monkey. Science 1979; 205: 929-932. (Pubitemid 10243358)
155. Collins P, Wilkinson LS, Everitt BJ, Robbins TW, Roberts AC,. The effect of dopamine depletion from the caudate nucleus of the common marmoset (Callithrix jacchus) on tests of prefrontal cognitive function. Behav Neurosci 2000; 114: 3-17. (Pubitemid 30131582)
156. Crofts HS, Dalley JW, Collins P, et al. Differential effects of 6-OHDA lesions of the frontal cortex and caudate nucleus on the ability to acquire an attentional set. Cereb Cortex 2001; 11: 1015-1026. (Pubitemid 33021232)
157. O'Neill M, Brown VJ,. The effect of striatal dopamine depletion and the adenosine A2A antagonist KW-6002 on reversal learning in rats. Neurobiol Learn Mem 2007; 88: 75-81. (Pubitemid 46809808)
158. Clarke HF, Hill GJ, Robbins TW, Roberts AC,. Dopamine, but not serotonin, regulates reversal learning in the marmoset caudate nucleus. J Neurosci 2011; 31: 4290-4297.
159. Landau SM, Lal R, O'Neil JP, Baker S, Jagust WJ,. Striatal dopamine and working memory. Cereb Cortex 2009; 19: 445-454.
160. Vernaleken I, Buchholz HG, Kumakura Y, et al. " Prefrontal" cognitive performance of healthy subjects positively correlates with cerebral FDOPA influx: an exploratory [18F]-fluoro-L-DOPA-PET investigation. Hum Brain Mapp 2007; 28: 931-939. (Pubitemid 47549698)
161. Cools R, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M,. Working memory capacity predicts dopamine synthesis capacity in the human striatum. J Neurosci 2008; 28: 1208-1212. (Pubitemid 351186336)
162. Cools R, Frank MJ, Gibbs SE, Miyakawa A, Jagust W, D'Esposito M,. Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. J Neurosci 2009; 29: 1538-1543.
163. Murphy BL, Arnsten AF, Goldman-Rakic PS, Roth RH,. Increased dopamine turnover in the prefrontal cortex impairs spatial working memory performance in rats and monkeys. Proc Natl Acad Sci USA 1996; 93: 1325-1329. (Pubitemid 26052888)
164. Cai JX, Arnsten AF,. Dose-dependent effects of the dopamine D1 receptor agonists A77636 or SKF81297 on spatial working memory in aged monkeys. J Pharmacol Exp Ther 1997; 283: 183-189. (Pubitemid 27438961)
165. Arnsten AF, Cai JX, Murphy BL, Goldman-Rakic PS,. Dopamine D1 receptor mechanisms in the cognitive performance of young adult and aged monkeys. Psychopharmacology (Berl) 1994; 116: 143-151. (Pubitemid 24317040)
166. Iversen LL, Iversen SD, Bloom FE, Roth RH, Introduction to Neuropsychopharmacology. Oxford: Oxford University Press; 2008.
167. Volkow ND, Chang L, Wang GJ, et al. Low level of brain dopamine D2 receptors in methamphetamine abusers: association with metabolism in the orbitofrontal cortex. Am J Psychiatry 2001; 158: 2015-2021. (Pubitemid 33104107)
168. Fehr C, Yakushev I, Hohmann N, et al. Association of low striatal dopamine d2 receptor availability with nicotine dependence similar to that seen with other drugs of abuse. Am J Psychiatry 2008; 165: 507-514. (Pubitemid 351694294)
169. Zijlstra F, Booij J, van den Brink W, Franken IH,. Striatal dopamine D2 receptor binding and dopamine release during cue-elicited craving in recently abstinent opiate-dependent males. Eur Neuropsychopharmacol 2008; 18: 262-270.
170. Tupala E, Hall H, Bergstrom K, et al. Dopamine D(2)/D(3)-receptor and transporter densities in nucleus accumbens and amygdala of type 1 and 2 alcoholics. Mol Psychiatry 2001; 6: 261-267. (Pubitemid 32275670)
171. Tupala E, Hall H, Bergstrom K, et al. Dopamine D2 receptors and transporters in type 1 and 2 alcoholics measured with human whole hemisphere autoradiography. Hum Brain Mapp 2003; 20: 91-102. (Pubitemid 37255116)
172. Martinez D, Gil R, Slifstein M, et al. Alcohol dependence is associated with blunted dopamine transmission in the ventral striatum. Biol Psychiatry 2005; 58: 779-786. (Pubitemid 41677416)
173. Volkow ND, Wang GJ, Telang F, et al. Low dopamine striatal D2 receptors are associated with prefrontal metabolism in obese subjects: possible contributing factors. Neuroimage 2008; 42: 1537-1543.
174. Nader MA, Morgan D, Gage HD, et al. PET imaging of dopamine D2 receptors during chronic cocaine self-administration in monkeys. Nat Neurosci 2006; 9: 1050-1056. (Pubitemid 44264918)
175. Thanos PK, Taintor NB, Rivera SN, et al. DRD2 gene transfer into the nucleus accumbens core of the alcohol preferring and nonpreferring rats attenuates alcohol drinking. Alcohol Clin Exp Res 2004; 28: 720-728. (Pubitemid 38661368)
176. Thanos PK, Volkow ND, Freimuth P, et al. Overexpression of dopamine D2 receptors reduces alcohol self-administration. J Neurochem 2001; 78: 1094-1103. (Pubitemid 32823158)
177. Johnson PM, Kenny PJ,. Dopamine D2 receptors in addiction-like reward dysfunction and compulsive eating in obese rats. Nat Neurosci 2010; 13: 635-641.
178. Thanos PK, Michaelides M, Umegaki H, Volkow ND,. D2R DNA transfer into the nucleus accumbens attenuates cocaine self-administration in rats. Synapse 2008; 62: 481-486. (Pubitemid 351794174)
179. Volkow ND, Wang GJ, Begleiter H, et al. High levels of dopamine D2 receptors in unaffected members of alcoholic families: possible protective factors. Arch Gen Psychiatry 2006; 63: 999-1008. (Pubitemid 44330458)
180. Thompson J, Thomas N, Singleton A, et al. D2 dopamine receptor gene (DRD2) Taq1 A polymorphism: reduced dopamine D2 receptor binding in the human striatum associated with the A1 allele. Pharmacogenetics 1997; 7: 479-484. (Pubitemid 27517576)
181. Colzato LS, van den Wildenberg WP, Van der Does AJ, Hommel B,. Genetic markers of striatal dopamine predict individual differences in dysfunctional, but not functional impulsivity. Neuroscience 2010; 170: 782-788.
182. Eisenberg DT, Mackillop J, Modi M, et al. Examining impulsivity as an endophenotype using a behavioral approach: a DRD2 TaqI A and DRD4 48-bp VNTR association study. Behav Brain Funct 2007; 3: 2.
183. Lee B, Groman S, London ED, Jentsch JD,. Dopamine D2/D3 receptors play a specific role in the reversal of a learned visual discrimination in monkeys. Neuropsychopharmacology 2007; 32: 2125-2134. (Pubitemid 47417686)
184. Boulougouris V, Castane A, Robbins TW,. Dopamine D2/D3 receptor agonist quinpirole impairs spatial reversal learning in rats: investigation of D3 receptor involvement in persistent behavior. Psychopharmacology (Berl) 2009; 202: 611-620.
185. Floresco SB, Magyar O, Ghods-Sharifi S, Vexelman C, Tse MT,. Multiple dopamine receptor subtypes in the medial prefrontal cortex of the rat regulate set-shifting. Neuropsychopharmacology 2006; 31: 297-309. (Pubitemid 43113395)
186. Laughlin RE, Grant TL, Williams RW, Jentsch JD,. Genetic dissection of behavioral flexibility: reversal learning in mice. Biol Psychiatry 2011; 69: 1109-1116.
187. Groman SM, Lee B, London ED, et al. Dorsal striatal D2-like receptor availability covaries with sensitivity to positive reinforcement during discrimination learning. J Neurosci 2011; 31: 7291-7299.
188. Luciana M, Depue RA, Arbisi P, Leon A,. Facilitation of working memory in humans by a D2 dopamine receptor agonist. J Cogn Neurosci 1992; 4: 58-68.
189. Bertolino A, Fazio L, Caforio G, et al. Functional variants of the dopamine receptor D2 gene modulate prefronto-striatal phenotypes in schizophrenia. Brain 2009; 132: 417-425.
190. Mehta MA, Manes FF, Magnolfi G, Sahakian BJ, Robbins TW,. Impaired set-shifting and dissociable effects on tests of spatial working memory following the dopamine D2 receptor antagonist sulpiride in human volunteers. Psychopharmacology (Berl) 2004; 176: 331-342. (Pubitemid 40012740)
191. Herold C,. NMDA and D2-like receptors modulate cognitive flexibility in a color discrimination reversal task in pigeons. Behav Neurosci 2010; 124: 381-390.
192. De Steno DA, Schmauss C,. A role for dopamine D2 receptors in reversal learning. Neuroscience 2009; 162: 118-127.
193. Glickstein SB, Desteno DA, Hof PR, Schmauss C,. Mice lacking dopamine D2 and D3 receptors exhibit differential activation of prefrontal cortical neurons during tasks requiring attention. Cereb Cortex 2005; 15: 1016-1024. (Pubitemid 40848070)
194. Jocham G, Klein TA, Neumann J, von Cramon DY, Reuter M, Ullsperger M,. Dopamine DRD2 polymorphism alters reversal learning and associated neural activity. J Neurosci 2009; 29: 3695-3704.
195. Ersche KD, Roiser JP, Abbott S, et al. Response perseveration in stimulant dependence is associated with striatal dysfunction and can be ameliorated by a D2/3 receptor agonist. Biol Psychiatry 2011; 70: 754-762.
196. Williams GV, Goldman-Rakic PS,. Modulation of memory fields by dopamine D1 receptors in prefrontal cortex. Nature 1995; 376: 572-575.
197. Sawaguchi T, Goldman-Rakic PS,. D1 dopamine receptors in prefrontal cortex: involvement in working memory. Science 1991; 251: 947-950. (Pubitemid 21926192)
198. Bechara A, Martin EM,. Impaired decision making related to working memory deficits in individuals with substance addictions. Neuropsychology 2004; 18: 152-162. (Pubitemid 38167184)
199. Gonzalez R, Bechara A, Martin EM,. Executive functions among individuals with methamphetamine or alcohol as drugs of choice: preliminary observations. J Clin Exp Neuropsychol 2007; 29: 155-159.
200. Martinez D, Slifstein M, Narendran R, et al. Dopamine D1 receptors in cocaine dependence measured with PET and the choice to self-administer cocaine. Neuropsychopharmacology 2009; 34: 1774-1782.
201. Dagher A, Bleicher C, Aston JA, Gunn RN, Clarke PB, Cumming P,. Reduced dopamine D1 receptor binding in the ventral striatum of cigarette smokers. Synapse 2001; 42: 48-53. (Pubitemid 32786423)
202. Woods JM, Ricken JD, Druse MJ,. Effects of chronic alcohol consumption and aging on dopamine D1 receptors in Fischer 344 rats. Alcohol Clin Exp Res 1995; 19: 1331-1337.
203. Macedo DS, Correia EE, Vasconcelos SM, Aguiar LM, Viana GS, Sousa FC,. Cocaine treatment causes early and long-lasting changes in muscarinic and dopaminergic receptors. Cell Mol Neurobiol 2004; 24: 129-136. (Pubitemid 38233736)
204. Nader MA, Daunais JB, Moore T, et al. Effects of cocaine self-administration on striatal dopamine systems in rhesus monkeys: initial and chronic exposure. Neuropsychopharmacology 2002; 27: 35-46. (Pubitemid 34626741)
205. Caine SB, Thomsen M, Gabriel KI, et al. Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. J Neurosci 2007; 27: 13140-13150. (Pubitemid 350220494)
206. Handelsman L, Rosenblum A, Palij M, et al. Bromocriptine for cocaine dependence. A controlled clinical trial. Am J Addict 1997; 6: 54-64. (Pubitemid 27089043)
207. Soares BG, Lima MS, Reisser AA, Farrell M,. Dopamine agonists for cocaine dependence. Cochrane Database Syst Rev 2001:CD003352.
208. Malcolm R, Kajdasz DK, Herron J, Anton RF, Brady KT,. A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug Alcohol Depend 2000; 60: 161-168. (Pubitemid 30625019)
209. Lawford BR, Young RM, Noble EP, et al. The D(2) dopamine receptor A(1) allele and opioid dependence: association with heroin use and response to methadone treatment. Am J Med Genet 2000; 96: 592-598.
210. Arinami T, Gao M, Hamaguchi H, Toru M,. A functional polymorphism in the promoter region of the dopamine D2 receptor gene is associated with schizophrenia. Hum Mol Genet 1997; 6: 577-582. (Pubitemid 27142107)
211. Lerman C, Jepson C, Wileyto EP, et al. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: results of two randomized clinical trials. Neuropsychopharmacology 2006; 31: 231-242. (Pubitemid 43250960)